Collagen-targeted PET imaging for progressive experimental lung fibrosis quantification and monitoring of efficacy of anti-fibrotic therapies.

 0 Người đánh giá. Xếp hạng trung bình 0

Tác giả: Pierre-Simon Bellaye, Philippe Bonniaud, Olivier Burgy, Bertrand Collin, Alan Courteau, Alexandre Magno Maneschy Dias, Romain Douhard, Carmen Garrido, Françoise Goirand, Victor Goncalves, Mélanie Guillemin, Alex Helbling, Mathieu Moreau, Alexandra Oudot, Lenny Pommerolle, John Simonet

Ngôn ngữ: eng

Ký hiệu phân loại:

Thông tin xuất bản: Australia : Theranostics , 2025

Mô tả vật lý:

Bộ sưu tập: NCBI

ID: 672816

Idiopathic pulmonary fibrosis (IPF) is a progressive disease characterized by an excessive collagen deposition ultimately leading to tissue stiffening and functional decline. Beyond IPF, other progressive pulmonary fibrosis are often associated with connective tissue diseases and may develop in ∼18-32% of patients. Therapeutic options are limited to nintedanib and pirfenidone which are only able to reduce fibrosis progression without curing it. The current lack of biomarker to accurately assess and predict disease progression and therapy efficacy for IPF remains a major clinical concern.
Tạo bộ sưu tập với mã QR

THƯ VIỆN - TRƯỜNG ĐẠI HỌC CÔNG NGHỆ TP.HCM

ĐT: (028) 36225755 | Email: tt.thuvien@hutech.edu.vn

Copyright @2024 THƯ VIỆN HUTECH